Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs.
Stitham J, Vanichakarn P, Ying L, Hwa J. Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs. 2014, 14: 909-31. PMID: 25109796, DOI: 10.2174/1566524014666140811121109.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Inflammatory Agents, Non-SteroidalCardiovascular DiseasesFibrinolytic AgentsGenetic Predisposition to DiseaseHumansPharmacogeneticsPlatelet Aggregation InhibitorsPolymorphism, Single NucleotidePrecision MedicineTreatment OutcomeConceptsNon-steroidal anti-inflammatory drugsAnti-inflammatory drugsCardiovascular pharmacogeneticsAdverse cardiovascular eventsAppropriate treatment regimenAnti-thrombotic agentsNSAID therapyCardiovascular eventsThromboembolic eventsCardiovascular implicationsCardiovascular riskPoor respondersTreatment regimenProspective screeningMyocardial infarctionAdverse reactionsAntithrombotic agentsCardiovascular diseaseHealthcare providersDrug efficacyGenetic biomarkersMedicationsIndividualized predictionInter-individual variationDrugs